Biosimilar Manufacturing solution center
-
Solving Glycoengineering Challenges Could Begin At The Cell Line
6/26/2026
Researchers produced a panel of platform cell lines illustrating how glycoform selection can be made experimentally visible earlier in biologics development.
-
What Biopharma Often Overlooks In A Scheduled Shutdown
6/26/2026
Shutting down an operating biologics facility upsets systems often designed for continuous operation. One expert shares his tips for preventing unnecessary problems.
-
LNP-Mediated Cell Transfection In Bioreactors Across Workflows
6/24/2026
Lipid nanoparticles are redefining immune cell engineering. Delve into new data that demonstrates the performance across multiple cell types and bioreactor systems, supporting their potential workflows.
-
Towards A Universal LNP Platform For Multiplex Engineering
6/19/2026
Multiplex engineering of T cells for solid tumors requires precise delivery. Emerging LNP approaches enable co-delivery of RNA and DNA, offering a safer, more scalable path beyond viral vectors.
-
Extrahepatic Delivery Of mRNA-LNP To Spleen
6/19/2026
In vivo CAR-T approaches aim to reprogram T cells directly in the body using targeted lipid nanoparticles. Improved delivery to immune organs highlights new potential for scalable cell therapies.
-
mRNA LNPs Drive Safe, Effective Repeat Dosing In Disease Models
6/19/2026
Well-designed lipid nanoparticles enable safe, efficient delivery. OVA-based models show how formulation choices shape efficacy, safety, and anti-tumor outcomes in melanoma research.
-
Discover A System That Can Be Used With Various Cell Culture Media
6/19/2026
Evolving CAR T cell therapies are raising the bar for manufacturing. Advances in cell expansion and the shift to serum-free media are redefining how scalable, future-ready processes are designed.
-
Developing CAR T Therapies With A Cell Therapy Manufacturing Platform
6/19/2026
Advances in CAR T cell engineering are expanding clinical potential, but manufacturing complexity limits scale. Integrated, automated workflows offer a path to consistent and efficient production.
-
A Practical Guide To Autologous CAR T Manufacturing
6/19/2026
Early process decisions shape scalability, consistency, and compliance in autologous CAR T manufacturing. Learn where variability emerges across the workflow and how to plan ahead.
-
Achieving High CAR T Cell Transduction Using An Automated Platform
6/19/2026
Automation is reshaping CAR T manufacturing. A modular, closed approach with digital integration supports efficient workflows while maintaining critical functional performance under GMP conditions.